CASI Pharmaceuticals (CASIF) Debt Ratio (2021 - 2025)

CASI Pharmaceuticals has reported Debt Ratio for 5 years, with the latest figure at 0.75 in Q4 2025.

• For the quarter ending Q4 2025, Debt Ratio rose 118.42% year-over-year to 0.75; the trailing twelve-month figure through Dec 2025 stood at 0.75 (up 118.42% YoY), and the FY2025 full-year result was 0.75, up 118.42% from the prior year.
• Debt Ratio for Q4 2025 stood at 0.75, up from 0.34 in the prior quarter.
• The five-year high for Debt Ratio was 360145.11 in Q2 2024, with the low at 0.1 in Q4 2021.
• Historically, Debt Ratio has averaged 51485.4 across 5 years, with a median of 0.34 in 2024.
• Annual changes were most pronounced in 2023 — Debt Ratio jumped 204267.03% — and 2024, when it plunged 99.86%.
• CASI Pharmaceuticals' Debt Ratio stood at 0.1 in 2021, then rose by 28.5% to 0.12 in 2022, then jumped by 204267.03% to 251.04 in 2023, then sank by 99.86% to 0.34 in 2024, then jumped by 118.42% to 0.75 in 2025.
• The last three Debt Ratio figures came in at 0.75 (Q4 2025), 0.34 (Q4 2024), and 360145.11 (Q2 2024), per Business Quant data.